Moleculin Biotech, Inc. (LON: 0K2H)
London flag London · Delayed Price · Currency is GBP · Price in USD
1.772
-0.053 (-2.93%)
At close: Jan 22, 2025

Moleculin Biotech Ratios and Metrics

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2015
Period Ending
Jan '25 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2015
Market Capitalization
42325393732
Upgrade
Market Cap Growth
-42.28%-10.59%-35.84%6.35%16.83%42.72%
Upgrade
Enterprise Value
-34-16-162820
Upgrade
Last Close Price
1.449.3714.1818.7781.0876.79
Upgrade
PB Ratio
1.081.100.580.672.842.69
Upgrade
P/TBV Ratio
-1.920.740.787.629.46
Upgrade
Debt / Equity Ratio
0.070.020.010.000.020.02
Upgrade
Quick Ratio
1.683.478.9619.595.203.01
Upgrade
Current Ratio
2.083.869.4620.025.893.78
Upgrade
Return on Equity (ROE)
-141.49%-76.07%-44.25%-32.85%-104.14%-88.50%
Upgrade
Return on Assets (ROA)
-57.45%-38.73%-27.06%-25.38%-45.48%-48.87%
Upgrade
Return on Capital (ROIC)
-82.70%-46.71%-29.06%-29.54%-72.61%-72.48%
Upgrade
Earnings Yield
-527.38%-103.79%-95.65%-29.90%-34.44%-31.56%
Upgrade
FCF Yield
-424.70%-84.46%-91.30%-35.69%-36.01%-41.22%
Upgrade
Buyback Yield / Dilution
-37.97%-3.60%-6.43%-172.97%-45.07%-57.20%
Upgrade
Total Shareholder Return
-37.97%-3.60%-6.43%-172.97%-45.07%-57.20%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.